With its eyes set on securing an FDA clearance for its automated bench top blood testing system, Truvian Sciences has raised more than $105 million in new financing for the final steps of its development. The series C round will also help scale up the company’s commercialization teams in preparation for launch—alongside several new appointments to its C-suite and board of directors
Category: FierceBiotech
Blood has always held the keys to our bodies’ health: it helps carry nutrients in and waste out, and interrogating it can provide solace when we are well and answers when we are sick
San Diego-based healthcare company Truvian Sciences wants to disrupt the $80 billion blood-testing market. The company closed a $27.1 million series B financing round, led by GreatPoint Ventures
Truvian Sciences raised $27.1 million to fuel the development of its benchtop blood tester, bringing the San Diego-based company’s total funding to date up to $46.3 million